Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade

The efficacy of current treatment regimens for pancreatic cancer (PC) remains unsatisfactory. In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-tumor outcomes in many malignancies, including PC. Inexpensive and readily available biomarkers which predict therapeutic r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Shang, Jin, Han, Xiao, Zha, Haoran, Tao, Haitao, Li, Xiaoyan, Yuan, Fang, Chen, Guangying, Wang, Lijie, Ma, Junxun, Hu, Yi
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943876/
https://ncbi.nlm.nih.gov/pubmed/33718140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.585271
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki